Affordable Access

Publisher Website

Nanoparticle-mediated local delivery of methylprednisolone after spinal cord injury

Authors
Journal
Biomaterials
0142-9612
Publisher
Elsevier
Publication Date
Volume
30
Issue
13
Identifiers
DOI: 10.1016/j.biomaterials.2008.12.077
Keywords
  • Nerve Regeneration
  • Inflammation
  • Hydrogel
  • Drug Delivery
Disciplines
  • Biology
  • Medicine

Abstract

Abstract Systemic administration of a high-dose of Methylprednisolone (MP) can reduce neurological deficits after acute spinal cord injury (SCI). However, the use of high-dose MP in treating acute SCI is controversial due to significant dose related side effects and relatively modest improvements in neurological function. Here, using a rat model of SCI, we compare the efficacy of controlled, nanoparticle-enabled local delivery of MP to the injured spinal cord with systemic delivery of MP, and a single local injection of MP without nanoparticles. Based on histological and behavioral data, we report that local, sustained delivery of MP via nanoparticles is significantly more effective than systemic delivery. Relative to systemic delivery, MP-nanoparticle therapy significantly reduced lesion volume and improved behavioral outcomes. Nanoparticle-enabled delivery of MP presents an effective method for introducing MP locally after SCI and significantly enhances therapeutic effectiveness compared to bare MP administered either systemically or locally.

There are no comments yet on this publication. Be the first to share your thoughts.